Oncology Overdrive

Oncology Overdrive

In this podcast by Healio, host Shikha Jain, MD, FACP, covers modern day health care in an ever-evolving world. Through interviews with experts, Jain explores hot topics in oncology and beyond.

  1. Enhancing Clinical Trial Enrollment with Michel van Harten, MD

    PRIJE 9 H

    Enhancing Clinical Trial Enrollment with Michel van Harten, MD

    In this episode, host Shikha Jain, MD, speaks with Michel van Harten, MD, about creating better information systems for physicians and patients, how shared decision-making can improve drug development and more. •    Welcome to another exciting episode of Oncology Overdrive 0:14 •    About van Harten 0:20 •    The interview 1:00 •    What was your journey to becoming a physician and beyond to where you are now? 1:24 •    How did you learn the necessary skills to be an exceptional leader in this space?  2:51 •    How many years were you a practicing physician for? 3:53 •    What does myTomorrows do, and what drew you to this type of work? 4:54 •    Where is this service available?  7:19 •    Jain and van Harten on the challenges patients face surrounding eligibility for clinical trials.  8:36 •    Where do you see this going down the line?  10:05 •    Has your company looked into how to these services can impact diversifying clinical trial enrollment?  12:04 •    What are some challenges your company has faced?  13:50 •    How quickly do you think growth will accelerate in this space?  15:26 •    How will this work and resource have major impacts on drug development in a more accelerated way than in the past?  16:11 •    From the patient-facing side, have you faced any challenges concerning patients’ willingness to be enrolled in clinical trials?  18:22 •    What is next for you, and where do you see yourself in twenty years?  19:13 •    Do you have any concerns about AI in health care? […] What should we be aware of when utilizing AI in this space?  19:45 •    Jain and van Harten on the challenges and setbacks that come from outdated and inaccurate clinical trial databases.  21:35 •    If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 23:50 •    How to contact van Harten 24:28 •    Thanks for listening 25:17 Michel van Harten, MD, is the CEO of myTomorrows. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Michel van Harten can be reached via email michel.vanharten@mytomorrows.com.  Disclosures: Jain and van Harten report no relevant financial disclosures.

    25 min
  2. The Data Behind Precision Medicine with Melody Harris

    PRIJE 6 D

    The Data Behind Precision Medicine with Melody Harris

    In this episode, host Shikha Jain, MD, speaks with Melody Harris about the evolution of precision medicine, what physicians and companies can do to help patients better understand precision oncology and more. •    Welcome to another exciting episode of Oncology Overdrive 0:14 •    About Harris 0:20 •    The interview 1:11 •    Tell us about how you ended up in this niche role. 1:32 •    How did you make the decision to move from practicing law to transitioning your career into this space?  3:56 •    Jain and Harris on the “hype” around precision medicine. 7:11 •    What is the central thesis of the work at NeoGenomics? 10:36 •    What do you feel companies need to be doing to make expectations surrounding diagnoses more transparent for patients?  11:49 •    Where do you think this is all going in the future? Where do you think we’ll be in another ten or twenty years?  13:30 •    What do you see yourself doing next?  19:04 •    How can companies address the disparities in health care access, especially in underserved areas?  21:06 •    If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 23:32 •    How to contact Harris 24:30 •    Thanks for listening 25:14 Melody Harris serves as chief operations officer and president of informatics at NeoGenomics, a leading oncology testing services company. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Harris can be reached at melody.harris@neogenomics.com.  Disclosures: Jain and Harris report no relevant financial disclosures.

    26 min
  3. Highlights from 2024 World Conference on Lung Cancer (Meeting Mic Re-Release)

    14. STU

    Highlights from 2024 World Conference on Lung Cancer (Meeting Mic Re-Release)

    In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting. With insights from Benjamin P. Levy, MD, and top headlines from the conference, Meeting Mic is your on-the-go source for highlights, pearls, and perspectives across all specialties. Benjamin P. Levy, MD, discusses key takeaways from the meeting. 0:49 Read the full coverage here: Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’ Source: Zhou C, et al. Abstract 2700. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. Perioperative nivolumab improves outcomes in resectable NSCLC Source: Forde PM, et al. Abstract 3589. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. Despite progress, barriers to lung cancer biomarker testing persist Source: Smeltzer M, et al. Abstract 3000. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Disclosures: Jain reports no relevant financial disclosures. Healio could not confirm relevant financial disclosures for Levy at the time of posting.

    19 min
  4. Health Care Advocacy During Elections with Alice Chen, MD

    31. LIS

    Health Care Advocacy During Elections with Alice Chen, MD

    In this episode, host Shikha Jain, MD, speaks with Alice Chen, MD, about the impact of misinformation and disinformation during elections, the health care issues on the 2024 ballot and more. Content warning: This episode discusses sensitive topics surrounding women’s health and reproductive rights. •    Welcome to another exciting episode of Oncology Overdrive 0:14 •    About Chen 0:32 •    The interview 1:38 •    How did you get into the public health and advocacy spaces? 1:58 •    Have you seen an evolution in medical professionals becoming more involved in politics and advocacy?  5:08 •    How has misinformation impacted politics, health care, policy and the election? 7:25 •    As health care workers, how do we address misinformation to help our communities and patients? 10:51 •    Do you feel that health care workers should use social media for this type of advocacy work?  15:26 •    Is there more of a need for health care workers to be doing this work now than it was pre-social media?  18:14 •    Jain and Chen on how discussions around politics have changed in the last decade.  26:05 •    What are the major health care topics being discussed and impacted by this upcoming election? Why is health on the ballot?  28:33 •    Jain and Chen on women’s health and why it matters in this election.  30:58 •    What are health care workers doing to promote advocacy?  37:05 •    If you could summarize this episode in one minute, what would you want listeners to take away? 45:36 •    How to contact Chen 46:11 •    Thanks for listening 46:53 Alice T. Chen, MD, is a mom, physician and national leader in public health, physician advocacy and community organizing.  She serves as the co-chair of the board of directors of Health Care Without Harm. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Chen can be reached @atychen on X and on LinkedIn.  Disclosures: Jain and Chen report no relevant financial disclosures.

    47 min
  5. Advocating for Patient Access with Amita Patnaik, MD, FRCPC

    17. LIS

    Advocating for Patient Access with Amita Patnaik, MD, FRCPC

    In this episode, host Shikha Jain, MD, speaks with Amita Patnaik, MD, FRCPC, about providing patient access to breakthrough drug developments, bringing early phase cancer trials to physicians and more. •    Welcome to another exciting episode of Oncology Overdrive 0:14 •    About Patnaik 0:21 •    The interview 1:23 •    How did you decide to become an oncologist, and how did you end up co-founding the START Center for Cancer Research?  1:32 •    Can you tell me about START’s overarching purpose and where you see its need being most fulfilled? […] What do you hope START will accomplish in the next five to ten years?  11:33 •    How successful has START been at including underrepresented patient populations in clinical data? 17:52 •    What are some challenges you’ve found as you have navigated through founding a company and executing its mission? 21:48 •    What is next for you?  25:21 •    If someone else wanted to create a company like START, what are some tips you would give them?  27:23 •    If someone could only listen to the last few minutes of this episode, what would you want them to take away? 32:03 •    How to contact Patnaik 34:44 •    Thanks for listening 35:27 Amita Patnaik, MD, FRCPC, is an internationally recognized medical oncologist and the co-founder of the START Center for Cancer Research. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Patnaik can be reached via email amita.patnaik@startresearch.com or via the START website.

    36 min
  6. Developing Products for Cancer Care with Annmarie Ison

    3. LIS

    Developing Products for Cancer Care with Annmarie Ison

    In this episode, host Shikha Jain, MD, speaks with Annmarie Ison about developing safe and accurate software, how software can improve health care disparities and more. •    Welcome to another exciting episode of Oncology Overdrive 0:14 •    About Ison 0:25 •    The interview 1:10 •    Tell me about how you got into this space […] Can you explain what software development is?  1:34 •    What is Elekta and what does the company do?  10:24 •    How do you feel that this type of innovation is transforming cancer care and treating oncology patients? 13:19 •    How is Elekta and its services helping to address health care disparities? 19:32 •    Where do you think AI fits into the bigger picture of the cancer care landscape?  24:53 •    If someone could only listen to the last few minutes of this episode, what would you want them to take away? 28:29 •    How to contact Ison 30:25 •    Thanks for listening 31:05 Annmarie Ison is head of customer service for the software business line at Elekta. She has over 25 years of experience as a software development professional, specializing in product development and software architecture for information management systems and radiation therapy delivery devices. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Ison can be reached via email annmarie.ison@elekta.com or via LinkedIn.  Disclosures: Jain and Ison report no relevant financial disclosures.

    31 min
  7. Entrepreneurship in Biotech with Brian Fiske

    19. RUJ

    Entrepreneurship in Biotech with Brian Fiske

    In this episode, host Shikha Jain, MD, speaks with Brian Fiske about bringing biotech business ideas to fruition, antibody drug conjugate developments and more. •    Welcome to another exciting episode of Oncology Overdrive 0:14 •    About Fiske 0:21 •    The interview 1:45 •    How did you get to where you are today, and how did you become interested in this specific area of health care?  2:06 •    What is a timeline from start to finish to bringing an innovative idea to fruition?  6:01 •    How long does it take to form an actual company from an idea?  11:20 •    How do you figure out who you need on your team to move an idea forward? 15:11 •    Tell us about your previous positions at biotech companies, and how did they help lead you into your current space? 20:22 •    What excites you about your job? […] Why do you feel the drive and desire to do this type of work?  24:40 •    Where do you see the work at Mythic Therapeutics doing in the next five to ten years for patient care?  26:27 •    How can we work towards making sure this type of innovative work is available and accessible to patients?  29:20 •    If someone could only listen to the last few minutes of this episode, what would you want them to take away? 31:16 •    How to contact Fiske 32:12 •    Thanks for listening 32:56 Brian Fiske is chief scientific officer and co-founder of Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate therapies for the treatment of a wide range of cancers. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Fiske can be reached via LinkedIn or the Mythic Therapeutics website.   Disclosures: Jain and Fiske report no relevant financial disclosures.

    33 min
  8. Women in medicine roundtable, Part 2: On empowerment and advocacy

    5. RUJ

    Women in medicine roundtable, Part 2: On empowerment and advocacy

    On this special edition episode, Shikha Jain, MD, with Physicianary’s Hansa Bhargava, MD, and Mend the Gap’s Dagny Zhu, MD, discuss the evolution of empowering yourself and others and advocacy with a panel of guests.  •    Intro 1:01 •    What does it mean to empower women in medicine, and what are the ways that we can really empower others to achieve the things that they may not see for themselves?  2:39 •    What are some ways in which you have empowered or hope to empower women in medicine? Are there tips or skills that have worked well?  5:43 •    How have you been empowered by others, or have helped others find their voices?  8:38 •    Do you agree that the conversation is changing toward a cultural shift in empowerment for women in health care? 13:53 •    What are some challenges facing advocacy and empowerment? What do you do when your advocacy work is not being received or it is a struggle to speak up for someone?  18:40 •    Emphasizing the importance of communication in advocacy work. 24:00 •    Intro to Physicianary’s part 3 on physician burnout and work-life balance. 24:16 •    Thanks for listening 25:00 Vineet Arora, MD, MAPP (NAM), is a Herbert T. Abelson professor of medicine, vice dean of education in the biological sciences division and dean for medical education at the University of Chicago Pritzker School of Medicine. She is also an elected member of the National Academy of Medicine. She is a founding member of the 501c3 Women of Impact and advisor to the Women in Medicine Summit. Jennifer Bepple, MD, MMCi, is a double board-certified physician in urology and informatics. She is a member of the American Telemedicine Association, American Urologic Association and American Medical Informatics Association and holds a certification from the American Board of Telehealth and the American Board of AI in Medicine. Hansa Bhargava, MD, is Healio's chief clinical strategy and innovation officer. Listen to her Healio podcast, Physicianary. Shikha Jain, MD, FACP, is a board-certified hematology and oncology physician. She is a tenured associate professor of medicine in the division of hematology and oncology, the director of communication strategies in medicine and the associate director of oncology communication & digital innovation at the University of Illinois Cancer Center in Chicago.  Mara Schenker, MD, FACS, FAOA, is an orthopedic trauma surgeon at Grady Memorial Hospital. She is double board certified in orthopedic surgery and clinical informatics. She serves as the chief of orthopedics and associate chief medical information officer.  She is an associate professor of orthopedics at Emory University School of Medicine. She serves on multiple boards for medical and digital technology advisory and sits on major national committees for the American Academy of Orthopaedic Surgeons, AAMC, American College of Surgeons and the Orthopaedic Trauma Association. Dagny Zhu, MD, is a cornea, cataract and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. She can be reached on X @DZEyeMD. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD.  Disclosures: The hosts and guest report no relevant financial disclosures.

    25 min

Opis

In this podcast by Healio, host Shikha Jain, MD, FACP, covers modern day health care in an ever-evolving world. Through interviews with experts, Jain explores hot topics in oncology and beyond.

Više od: Healio

Također bi vam se moglo svidjeti

Da biste slušali eksplicitne epizode, prijavite se

Budite u tijeku s ovom emisijom

Prijavite se ili se registrirajte da biste pratili emisije, spremali epizode i primali najnovija ažuriranja.

Odaberite zemlju ili regiju

Afrika, Bliski istok i Indija

Azijsko-pacifičke zemlje

Europa

Latinska Amerika i Karibi

Sjedinjene Američke Države i Kanada